Premium
Corticospinal Excitability and Inhibition of the Soleus in Individuals With Chronic Ankle Instability
Author(s) -
Terada Masafumi,
Bowker Samantha,
Thomas Abbey C.,
Pietrosimone Brian,
Hiller Claire E.,
Gribble Phillip A.
Publication year - 2016
Publication title -
pmandr
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.617
H-Index - 66
eISSN - 1934-1563
pISSN - 1934-1482
DOI - 10.1016/j.pmrj.2016.04.006
Subject(s) - transcranial magnetic stimulation , soleus muscle , ankle , medicine , physical medicine and rehabilitation , electromyography , motor cortex , stimulation , silent period , corticospinal tract , neuroscience , functional electrical stimulation , physical therapy , psychology , anatomy , magnetic resonance imaging , skeletal muscle , radiology , diffusion mri
Background Understanding the mechanisms of neurophysiological alterations with chronic ankle instability (CAI) may be essential in the development of the most‐effective intervention programs to treat neuromuscular dysfunction in patients with CAI. Specifically, the presence of CAI may be associated with an altered supraspinal mechanism within the central nervous system to inhibit neural drive to the undamaged soleus surrounding the injured ankle joint. Objective To investigate the influence of CAI on corticospinal excitability and inhibition of the soleus. Design A single‐blinded, case‐control study. Setting Research laboratory. Participants Sixteen participants with self‐reported CAI and 17 healthy control participants volunteered. Methods Transcranial magnetic stimulation was used to assess corticospinal excitability and inhibition of the soleus muscle. Active motor threshold (AMT), defined as the lowest stimulator intensity required to elicit a peak‐to‐peak motor‐evoked potential (MEP) amplitude ≥100 μV in at least four of 8 trials, was found to assess corticospinal excitability of the soleus. Eight stimuli were delivered at 120% of AMT, and peak‐to‐peak MEP amplitudes were recorded for each trial. The amplitude of 8 MEPs at 120% of AMP were averaged and normalized to the maximum M‐response. Cortical silent period (CSP) was measured as the distance from the end of the MEP to a return of the mean electromyographic signal plus 2 times the standard deviation of the baseline (prestimulus) electromyographic signal. The ratio of the CSP to the MEP at 120% AMT (CSP:MEP 120 ) were calculated to assess corticospinal inhibition. Results The CAI group had a greater CSP:MEP 120 ratio compared with the control group ( P = .02). No significant differences between groups were observed for AMT ( P = .67) and normalized MEP at 120% of AMT ( P = .42). Conclusions The greater CSP:MEP 120 ratio in participants with CAI suggests an altered balance in corticospinal inhibition and excitability to the soleus of the CAI cohort. Future research is needed to determine the role of corticospinal inhibition in physical and self‐reported function in patients with CAI. Level of Evidence IV